Causality assessment of herb-induced liver injury using multidisciplinary approach and Roussel Uclaf Causality Assessment Method (RUCAM)

Clinical Toxicology

Volumn 49, Issue 1, 2011, Pages 34-39

  Chau, Tai Nin ^a   Cheung, Wing I ^a   Ngan, Teresa ^b   Lin, Jieru ^b   Lee, Ken Wing San ^b   Poon, Wing Tat ^c   Leung, Vincent King Sun ^a   Mak, Tony ^c   Tse, Man Li ^a  

^a UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

^c PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

Causality assessment; Chinese medicine; Diagnosis; Herbs; Multidisciplinary approach

Indexed keywords

HERBACEOUS AGENT;

ADULT; AGED; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CLINICAL EXAMINATION; CONSENSUS DEVELOPMENT; DATA BASE; DATA COLLECTION METHOD; DISEASE COURSE; EPIDEMIOLOGY; FEMALE; HEALTH CARE QUALITY; HERB; HERBAL MEDICINE; HUMAN; INFORMATION RETRIEVAL; LIVER CELL DAMAGE; LIVER INJURY; MALE; PHARMACIST; PRESCRIPTION; ROUSSEL UCLAF CAUSALITY ASSESSMENT METHOD;

ADULT; AGED; ALGORITHMS; DRUG-INDUCED LIVER INJURY; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT;

EID: 79551656518     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2010.537662     Document Type: Article

References (12)

1. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC. Trends in alternative use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280:1569-1975.
2. Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J. Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135:1924-1934.
3. Wai CT, Tan BH, Chan CL, Sutedja DS, Lee YM, Khor C, Lim SG. Drug-induced liver injury at an Asian center: a prospective study. Liver Int 2007; 27:465-474.
4. Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46:1323-1330.
5. Chan TYK, Tam HP, Lai CK, Chan AYW. A multidisciplinary approach to the toxicologic problems associated with the use of herbal medicines. Ther Drug Monit 2005; 27:53-57.
6. Benichou C. Criteria of drug-induced liver disorders: report of an international consensus meeting. J Hepatol 1990; 11:272-276.
7. Centre for Evidence-Based Medicine. Levels of Evidence and Grades of Recommendation. http://www.cebm.net/index.aspx?o=5653. (Accessed 15 June 2010).
8. Lai CK, Lee T, Au KM, Chan AY. Uniform solid-phase extraction procedure for toxicological drug screening in serum and urine by HPLC with photodiode-array detection. Clin Chem 1997; 43:312-325.
9. Poon WT, Chau TL, Lai CK, Tse KY, Chan YC, Leung KS, Chan YW. Hepatitis induced by Teucrium viscidum. Clin Toxicol 2008; 46(9):819-822.
10. Rochon J, Protiva P, Seeff LB, Fontana RJ, Liangpunsakul S, Watkins PB, Davern T, McHutchison JG. Drug-Induced Liver Injury Network (DILIN). Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury. Hepatology 2008; 48:1175-1183.
11. Rockey DC, Seeff LB, Rochon J, Freston J, Chalasani N, Bonacini M, Fontana RJ, Hayashi PH. US Drug-Induced Liver Injury Network. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf Causality Assessment Method. Hepatology 2010; 51:2117-2126.
12. Chang HM, But PPH. Pharmacology and Application of Chinese Materia Medica. Vol. 1, 2. Singapore: World Scientific; 1987.